Erlotinib (Tarceva) experience in a public health system, minority patient population with progressive metastatic non-small cell lung cancer (mNSCLC)

被引：0
|
作者：
Nathan, Sunita [1 ]
Patel, Pritesh [1 ]
Sharma, Jennifer [1 ]
Samuel, Joyce [1 ]
Stroger, John H., Jr. [1 ]
机构：
[1] Cook Cty Hosp, Chicago, IL USA
来源：
CHEST | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：588S / 589S
页数：2
相关论文
共 50 条
  • [41] Combination of quinacrine and erlotinib overcomes resistance to erlotinib in non-small cell lung cancer
    Dermavvan, Josephine Kam Tai
    Gurova, Katerina
    Pink, John
    Dowlati, Afshin
    De, Sarmishtha
    Naria, Goutham
    Sharma, Neelesh
    Stark, George
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [42] True abscopal effect in a patient with metastatic non-small cell lung cancer
    Vilinovszki, Oliver
    Andratschke, Nicolaus
    Huellner, Martin
    Curioni-Fontecedro, Alessandra
    Kroeze, Stephanie G. C.
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [43] True abscopal effect in a patient with metastatic non-small cell lung cancer
    Oliver Vilinovszki
    Nicolaus Andratschke
    Martin Huellner
    Alessandra Curioni-Fontecedro
    Stephanie G. C. Kroeze
    Radiation Oncology, 16
  • [44] Erlotinib Response in a Non-Small Cell Lung Cancer Patient with EGFR Exon 20 Mutation
    Korkmaz, Levent
    Artac, Mehmet
    Karaagac, Mustafa
    Er, Zehra
    Boruban, Melih C.
    Poyraz, Necdet
    Kaya, Bugra
    Tavli, Lema
    Odev, Kemal
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2016, 26 (01): : 64 - 66
  • [45] Metastatic Non-Small Cell Lung Cancer to the Small Bowel
    Levy, Sara
    Shroff, Sagar
    Qayed, Emad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S421 - S421
  • [46] Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis
    Franchina, T.
    Adamo, B.
    Caristi, N.
    Chiofalo, G.
    Toscano, G.
    Colonese, F.
    Denaro, N.
    Ricciardi, G. R.
    Russo, A.
    Adamo, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] Approval Summary: Erlotinib Maintenance Therapy of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Cohen, Martin H.
    Johnson, John R.
    Chattopadhyay, Somesh
    Tang, Shenghui
    Justice, Robert
    Sridhara, Rajeshwari
    Pazdur, Richard
    ONCOLOGIST, 2010, 15 (12): : 1344 - 1351
  • [48] Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug-drug interaction
    Das, Millie
    Padda, Sukhmani K.
    Frymoyer, Adam
    Zhou, Lisa
    Riess, Jonathan W.
    Neal, Joel W.
    Wakelee, Heather A.
    LUNG CANCER, 2015, 89 (03) : 280 - 286
  • [49] LKB1 Mutations in Metastatic Non-Small Cell Lung Cancer (mNSCLC): Prognostic Value in the Real World
    Golozar, A.
    Collins, J.
    Fraeman, K.
    Nordstrom, B.
    Mcewen, R.
    Shire, N.
    Higgs, B.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S223 - S224
  • [50] Economic Burden of Metastatic Non-Small Cell Lung Cancer (mNSCLC) in a Large United States (US) Claims Database
    Chou, E.
    Ganti, A. K.
    Katranji, K.
    Cotarla, I.
    Sharma, C.
    Miao, B.
    Garg, M.
    Seal, B.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S11 - S12
12345